Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice

Neuroscience

Volumn 116, Issue 4, 2003, Pages 1123-1130

  Fernagut, P O ^a   Chalon, S ^b   Diguet, E ^a   Guilloteau, D ^b   Tison, F ^a   Jaber, M ^b  

^a CNRS   (France)

^b INSERM   (France)

Author keywords

D1 receptor; D2 receptor; Dopamine; Motor behaviour; PE2I; Striatum

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; HINDLIMB; HISTOPATHOLOGY; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MOTOR ACTIVITY; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; MUTANT; NERVE FUNCTION; NERVOUS SYSTEM FUNCTION; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECEPTOR BINDING; SENSORIMOTOR FUNCTION; STRAIN DIFFERENCE; STRIATE CORTEX; SUBSTANTIA NIGRA; TASK PERFORMANCE; WILD TYPE;

EID: 0344407056     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00778-9     Document Type: Article

References (45)

1. Barbier P., Colelli A., Maggio R., Bravi D., Corsini G.U. Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration. J Neural Transm. 104:1997;867-874.
2. Benoit-Marand M., Jaber M., Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter functional consequences . Eur J Neurosci. 12:2000;2985-2992.
3. Bosse R., Fumagalli F., Jaber M., Giros B., Gainetdinov R.R., Wetsel W.C., Missale C., Caron M.G. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19:1997;127-138.
4. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry comparison with dopamine D2 receptor mRNA . Brain Res. 564:1991;203-219.
5. Calabresi P., Gubellini P., Picconi B., Centonze D., Pisani A., Bonsi P., Greengard P., Hipskind R.A., Borrelli E., Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci. 21:2001;5110-5120.
6. Carter R.J., Lione L.A., Humby T., Mangiani L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci. 19:1999;3248-3257.
7. Cass W.A., Gerhardt G.A., Mayfield R.D., Curella P., Zahniser N.R. Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem. 59:1992;259-266.
8. Chalon S., Garreau L., Emond P., Zimmer L., Vilar M.P., Besnard J.C., Guilloteau D. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′- methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter. J Pharmacol Exp Ther. 291:1999;648-654.
9. 3H]spiperone binding evidence for accumulation in corpus striatum by agonist-mediated receptor internalization . J Cereb Blood Flow Metab. 8:1988;291-303.
10. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., Levey A.I. The dopamine transporter immunochemical characterization and localization in brain . J Neurosci. 15:1995;1714-1723.
11. Dulawa S.C., Grandy D.K., Low M.J., Paulus M.P., Geyer M.A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci. 19:1999;9550-9556.
12. Dumartin B., Jaber M., Gonon F., Caron M.G., Giros B., Bloch B. Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. Proc Natl Acad Sci USA. 97:2000;1879-1884.
13. Eradiri O.L., Starr M.S. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. Eur J Pharmacol. 386:1999;217-226.
14. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse a 1H MRS study . Neurology. 54:2000;1344-1349.
15. Fauchey V., Jaber M., Caron M.G., Bloch B., Le Moine C. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur J Neurosci. 12:2000;19-26.
16. Fernagut P.O., Diguet E., Labattu B., Tison F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods. 113:2002;123-130.
17. Fernagut P.O., Diguet E., Stefanova N., Biran M., Wenning G.K., Canioni P., Bioulac B., Tison F. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice behavioural and histopathological characterization . Neuroscience. 2002;. in press.
18. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kuemmerle S., Kubilus J.K., Kaddurah-Daouk R., Hersch S.M., Beal M.F. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci. 20:2000;4389-4397.
19. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates. 1st ed:1997;Academic Press, New York.
20. Gahtan E., Auerbach J.M., Groner Y., Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci. 10:1998;538-544.
21. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 283:1999;397-401.
22. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci. 14:1993;43-49.
23. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
24. Ghorayeb I., Puschban Z., Fernagut P.O., Scherfler C., Rouland R., Wenning G.K., Tison F. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection a model of early-stage striatonigral degeneration . Exp Neurol. 167:2001;133-147.
25. Guyot M.C., Hantraye P., Dolan R., Palfi S., Maziere M., Brouillet E. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience. 79:1997;45-56.
26. Jaber M., Dumartin B., Sagne C., Haycock J.W., Roubert C., Giros B., Bloch B., Caron M.G. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci. 11:1999;3499-3511.
27. Jakel R.J., Maragos W.F. Neuronal cell death in Huntington's disease a potential role for dopamine . Trends Neurosci. 23:2000;239-245.
28. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA. 95:1998;4029-4034.
29. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman M., White F.J., Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci. 2:1999;649-655.
30. Korpi E.R., Koikkalainen P., Vekovischeva O.Y., Makela R., Kleinz R., Uusi-Oukari M., Wisden W. Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-induced ataxia evidence from alpha 6-subunit-deficient mice . Eur J Neurosci. 11:1999;233-240.
31. Levant B. The D3 dopamine receptor neurobiology and potential clinical relevance . Pharmacol Rev. 49:1997;231-252.
32. Luo Y., Hattori A., Muno J., Qin Z.H., Roth G.S. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Mol Pharmacol. 56:1999;254-264.
33. Matsuura K., Kabuto H., Makino H., Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 73:1997;45-48.
34. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem. 70:1998;2406-2415.
35. Pisa M. Motor functions of the striatum in the rat critical role of the lateral region in tongue and forelimb reaching . Neuroscience. 24:1988;453-463.
36. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice differential effects of D1 and D2 receptor antagonists . J Neurosci. 21:2001;305-313.
37. Reynolds D.S., Carter R.J., Morton A.J. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci. 18:1998;10116-10127.
38. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
39. Roberts R.C., Ahn A., Swartz K.J., Beal M.F., DiFiglia M. Intrastriatal injections of quinolinic acid or kainic acid differential patterns of cell survival and the effects of data analysis on outcome . Exp Neurol. 124:1993;274-282.
40. Rondi-Reig L., Lohof A., Dubreuil Y.L., Delhaye-Bouchaud N., Martinou J.C., Caston J., Mariani J. Hu-Bcl-2 transgenic mice with supernumerary neurons exhibit timing impairment in a complex motor task. Eur J Neurosci. 11:1999;2285-2290.
41. Rozas G., Lopez-Martin E., Guerra M.J., Labandeira-Garcia J.L. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods. 83:1998;165-175.
42. Sedelis M., Schwarting R.K., Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res. 125:2001;109-125.
43. Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C., Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol. 11:2000;279-290.
44. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur J Pharmacol. 173:1989;177-182.
45. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M.J., Gatley S.J., Hitzemann R., Ding Y.S., Wong C., Logan J. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry. 158:2001;383-389.